Literature DB >> 19208679

Utility assessment among patients of primary angle closure/glaucoma in China: a preliminary study.

X Sun1, S Zhang, N Wang, Y Liang, L Wang, S Fan, L Sun.   

Abstract

AIM: To evaluate utility values among patients of primary angle closure/glaucoma (PAC/G) in a local hospital in China, and the factors influencing the quality of their lives.
METHODS: A cross-sectional study. Utility values were measured using the time trade-off (TTO) and standard gamble (gamble for blindness) methods. Standard face-to-face interviews were conducted. Results of ophthalmic examinations were recorded.
RESULTS: One hundred and six patients were recruited, 16 (15.1%) male and 90 (84.9%) female, mean age 63.21 years (SD 7.46). Fifty-five (50.9%) patients had a history of acute angle closure (AAC). The mean duration from glaucoma diagnosed to the day of interview was 7.69 (3.30) months. All participants underwent laser therapy, and 12 patients (11.3%) also received trabeculectomies. The mean utility value was 0.75 (0.14) (95% CI 0.73 to 0.78) with the TTO technique and 0.80 (0.08) (95% CI 0.78 to 0.81) with the standard gamble (SG) technique. The correlation between the two values was significant (p<0.001). Age, educational status, better best-corrected visual acuity (BCVA), worse BCVA and better visual field had significant effects on the utility values. Patients' self-evaluation of the impact of PAC/G upon their lives correlated with the TTO utility values (p = 0.008) and not with the SG utility values (p = 0.652).
CONCLUSION: The mean TTO utility score of the studied population is 0.75. The utility value is directly dependent on age, the degree of visual function loss and educational status. It is likely that patients find the TTO method easier to comprehend than the SG method.

Entities:  

Mesh:

Year:  2009        PMID: 19208679     DOI: 10.1136/bjo.2008.139295

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Time Trade-off Utility Values in Noninfectious Uveitis.

Authors:  Katherine M Niemeyer; John A Gonzales; Thuy Doan; Erica N Browne; Maya M Rao; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2019-06-13       Impact factor: 5.258

Review 2.  [Value-based medicine for glaucoma].

Authors:  C Hirneiss; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

3.  Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma.

Authors:  Y-S Kuo; C J-L Liu; H-C Cheng; M-J Chen; W-T Chen; Y-C Ko
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

4.  Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants.

Authors:  Kulawan Rojananuangnit; Nuttawan Sudjinda
Journal:  Clin Ophthalmol       Date:  2021-02-25

5.  Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections.

Authors:  Wantanee Kulpeng; Vorasith Sornsrivichai; Virasakdi Chongsuvivatwong; Waranya Rattanavipapong; Pattara Leelahavarong; John Cairns; Yoel Lubell; Yot Teerawattananon
Journal:  BMC Pediatr       Date:  2013-08-13       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.